BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1516 related articles for article (PubMed ID: 29141691)

  • 1. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.
    Tao T; Liu D; Liu C; Xu B; Chen S; Yin Y; Ang L; Huang Y; Zhang X; Chen M
    Biochim Biophys Acta; 2014 Sep; 1839(9):858-65. PubMed ID: 25017995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
    Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
    Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
    Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y
    Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
    Han L; Zhang HC; Li L; Li CX; Di X; Qu X
    Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2.
    Sun XB; Chen YW; Yao QS; Chen XH; He M; Chen CB; Yang Y; Gong XX; Huang L
    Technol Cancer Res Treat; 2021; 20():1533033821989817. PubMed ID: 33550923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
    Luo JF; Xu J; Zheng JZ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.
    Chiyomaru T; Yamamura S; Fukuhara S; Yoshino H; Kinoshita T; Majid S; Saini S; Chang I; Tanaka Y; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(8):e70372. PubMed ID: 23936419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
    Song BF; Xu LZ; Jiang K; Cheng F
    Funct Integr Genomics; 2023 Mar; 23(2):80. PubMed ID: 36884182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.
    Huang K; Tang Y
    Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.
    Song H; Liu Y; Jin X; Liu Y; Yang Y; Li L; Wang X; Li G
    J Cell Mol Med; 2019 Sep; 23(9):6098-6111. PubMed ID: 31273925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.